Viridian Therapeutics, Inc. (VRDN) Discusses Positive Topline Results from Elegrobart REVEAL-1 Phase III Trial in Active Thyroid Eye Disease Transcript By Cryo Mantis · April 2, 2026 · 1 min read vrdnsa transcripts Source: seekingalpha.com